Hospital
Margaret Mary Community Hospital INC
Margaret Mary Community Hospital INC was paid $7.96M by Medicaid between Jan 2018 and Nov 2024, across 114 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoMARGARET MARY COMMUNITY HOSPITAL INC
BATESVILLE, IN 47006
BATESVILLE, IN 47006
33aNPI1558368449assigned 07/07/2005
33bProvider typeCritical Access Hospital
28Total paid$7.96M
24GClaims211,834
24DCodes billed114
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#5 of 26
Median peer was paid$4.16M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,826 | $489K | |
| 2019 | 33,362 | $736K | |
| 2020 | 27,390 | $761K | |
| 2021 | 33,567 | $1.42M | |
| 2022 | 43,995 | $2.09M | |
| 2023 | 29,164 | $1.46M | |
| 2024incomplete | 20,530 | $1.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 24,362 | 19,476 | $3.17M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 15,811 | 11,345 | $1.31M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.0% | 6,424 | 5,254 | $638K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5.2% | 4,112 | 3,527 | $416K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.6% | 4,625 | 3,381 | $364K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 6,717 | 3,991 | $312K |
| 71046 | Radiologic examination, chest; 2 views | 3.3% | 2,030 | 1,723 | $262K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 4,027 | 2,996 | $168K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.6% | 2,375 | 1,758 | $129K |
| 80053 | Comprehensive metabolic panel | 1.5% | 20,826 | 16,057 | $123K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 1,563 | 1,151 | $112K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 22,732 | 16,912 | $111K |
102 more codes
| 59025 | Fetal non-stress test | 1.4% | 389 | $110K |
| 36415 | Collection of venous blood by venipuncture | <1% | 34,259 | $78K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,512 | $76K |
| 97597 | <1% | 915 | $61K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,250 | $47K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 128 | $44K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,409 | $38K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 865 | $34K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,295 | $24K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 783 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 767 | $22K |
| 80061 | Lipid panel | <1% | 2,611 | $20K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,635 | $19K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,732 | $19K |
| G0378 | Hospital observation service, per hour | <1% | 305 | $14K |
| 84484 | <1% | 2,224 | $13K | |
| 81001 | <1% | 6,986 | $12K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 77 | $12K |
| 83605 | <1% | 2,179 | $11K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 209 | $10K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 82 | $10K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 51 | $10K |
| 76830 | Ultrasound, transvaginal | <1% | 51 | $10K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,936 | $8K |
| 87631 | <1% | 97 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 99 | $8K |
| 84145 | <1% | 767 | $7K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 600 | $7K |
| 83690 | <1% | 1,791 | $6K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 87 | $6K |
| 99218 | <1% | 21 | $6K | |
| 81025 | <1% | 857 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 613 | $5K |
| 94761 | <1% | 122 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,007 | $4K |
| 87040 | <1% | 1,115 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 229 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 247 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,615 | $3K |
| 85730 | <1% | 1,025 | $3K | |
| 74018 | <1% | 22 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 142 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,287 | $3K |
| 85610 | <1% | 1,196 | $3K | |
| 83880 | <1% | 250 | $3K | |
| 82803 | <1% | 192 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 45 | $2K |
| 81003 | <1% | 625 | $2K | |
| 80306 | <1% | 137 | $2K | |
| 73630 | <1% | 48 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $1K |
| 85027 | <1% | 351 | $1K | |
| 82150 | <1% | 433 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 55 | $1K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 1,142 | $1K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 15 | $981.30 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 37 | $964.77 |
| 92567 | <1% | 14 | $932.30 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 28 | $750.46 |
| 87660 | <1% | 42 | $700.55 | |
| 87480 | <1% | 42 | $700.55 | |
| 87510 | <1% | 42 | $700.55 | |
| 86850 | <1% | 124 | $521.27 | |
| 99223 | Prolong inpt eval add15 m | <1% | 14 | $457.98 |
| 86780 | <1% | 41 | $393.23 | |
| 83735 | <1% | 116 | $390.57 | |
| 85379 | <1% | 47 | $353.49 | |
| 86762 | <1% | 27 | $297.88 | |
| 86803 | <1% | 27 | $295.30 | |
| 86703 | <1% | 27 | $283.74 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 105 | $266.40 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 684 | $252.23 |
| 86900 | <1% | 123 | $229.26 | |
| 87186 | <1% | 42 | $229.02 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 33 | $220.32 |
| 99217 | <1% | 26 | $216.62 | |
| 86901 | <1% | 107 | $203.50 | |
| 87340 | <1% | 27 | $189.86 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $138.47 |
| 81002 | <1% | 112 | $126.90 | |
| 82728 | <1% | 18 | $102.11 | |
| 80076 | <1% | 33 | $89.87 | |
| 84439 | <1% | 12 | $87.50 | |
| 82465 | <1% | 20 | $60.97 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 809 | $39.59 |
| 83874 | <1% | 19 | $33.43 | |
| A9270 | Non-covered item or service | <1% | 1,183 | $27.72 |
| 82553 | <1% | 19 | $17.57 | |
| 82550 | <1% | 19 | $16.85 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,958 | $3.06 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 447 | $2.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 231 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 15 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 45 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 26 | $0.00 |
| 82248 | 0% | 16 | $0.00 | |
| 83540 | 0% | 16 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 371 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 83 | $0.00 |
| 82607 | 0% | 63 | $0.00 | |
| 90686 | 0% | 17 | $0.00 | |
| 83550 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAEGER, BRIAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Margaret Mary Community Hospital, INC | Batesville, IN | $4.75M |
| Margaret Mary Community Hospital, INC. | Osgood, IN | $1.08M |
| Margaret Mary Community Hospital, INC. | Brookville, IN | $155K |
| Margaret Mary Community Hospital, INC. | Batesville, IN | $146K |
| Margaret Mary Community Hospital, INC. | Batesville, IN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.